We previously demonstrated that siRNA-based knockdown of TRPM4 increases SOCE (Fig. 1) and reduces cell migration in the prostate cancer cell lines DU145 and PC3 [105•, 106]. Here, TRPM4 is linked to prostate carcinoma.